Match!
Byeong Geun Song
Samsung Medical Center
4Publications
1H-index
6Citations
Publications 4
Newest
#1Jun Sik Yoon (Inje University)
#2Byeong Geun Song (SMC: Samsung Medical Center)H-Index: 1
Last.Dong Hyun Sinn (SMC: Samsung Medical Center)H-Index: 19
view all 10 authors...
Background Several randomized controlled trials have shown that adjuvant immunotherapy with autologous cytokine-induced killer (CIK) cells prolongs recurrence-free survival (RFS) after curative treatment for hepatocellular carcinoma (HCC). We investigated the efficacy of adjuvant immunotherapy with activated CIK cells in real-world clinical practice.
#1Byeong Geun Song (SMC: Samsung Medical Center)H-Index: 1
#2Jae Keun Park (SMC: Samsung Medical Center)H-Index: 1
Last.Hyuk-JoonLee (SMC: Samsung Medical Center)H-Index: 170
view all 8 authors...
AbstractObjective: Previous studies have revealed that biliary tract cancer (BTC) has different clinical characteristics depending on its anatomical location. However, clinical studies about the prognosis of BTC according to its anatomical location are lacking. We aimed to compare the prognosis of BTC according to its anatomical location.Methods: We retrospectively reviewed records of 311 patients with advanced BTC who received gemcitabine based palliative chemotherapy from January 2006 to Decem...
#1Byeong Geun Song (SMC: Samsung Medical Center)H-Index: 1
#2Yang Won Min (SMC: Samsung Medical Center)H-Index: 14
Last.J Kim (SMC: Samsung Medical Center)H-Index: 34
view all 7 authors...
Background Endoscopic submucosal dissection (ESD) has been widely accepted for treating superficial esophageal squamous cell carcinoma (SESCC). The aim of this study was to evaluate the efficacy and safety of ESD for SESCC and the effect of different sedation methods on their clinical outcomes.
#1Yang Won Min (SMC: Samsung Medical Center)H-Index: 14
#2Hyuk-JoonLee (SMC: Samsung Medical Center)H-Index: 170
Last.Jae Ill Zo (SMC: Samsung Medical Center)H-Index: 24
view all 10 authors...
Background and Aims Endoscopic submucosal dissection (ESD) has been widely accepted for treating superficial esophageal squamous cell carcinoma (SESCC). However, long-term outcomes of ESD and esophagectomy for SESCC have not been compared. We compared the clinical outcomes of ESD and esophagectomy in a matched cohort. Methods Patients who underwent ESD and esophagectomy for SESCC were included. We selected SESCCs without obvious submucosal invasion from the surgical database by reviewing endosco...
1